What is it about?
To evaluate the efficacy and safety of most selective serotonin reuptake inhibitor drug, escitalopram, in delaying ejaculation in patients with premature ejaculation (PE).
Photo by Kristina Litvjak on Unsplash
Why is it important?
Premature ejaculation is the most common form of sexual dysfunction in men, affecting up to 21% of men aged 18 to 59 years in the United States.1 In general, however, the prevalence of PE is reported as being between 22% and 38% of adult male population
Read the Original
This page is a summary of: Safety and Efficacy of Escitalopram in the Treatment of Premature Ejaculation, Journal of Clinical Psychopharmacology, October 2007, Wolters Kluwer Health, DOI: 10.1097/jcp.0b013e31814b98d4.
You can read the full text:
The following have contributed to this page